Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex

Potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A

A. Zsarnovszky, Hoa H. Le, Hong Sheng Wang, Scott M. Belcher

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

In addition to regulating estrogen receptor-dependent gene expression, 17β-estradiol (E2) can directly influence intracellular signaling. In primary cultured cerebellar neurons, E2 was previously shown to regulate growth and oncotic cell death via rapid stimulation of ERK1/2 signaling. Here we show that ERK1/2 signaling in the cerebellum of neonatal and mature rats was rapidly responsive to E2 and during development to the environmental estrogen bisphenolA(BPA). In vivo dose-response analysis for each estrogenic compound was performed by brief (6-min) intracerebellar injection, followed by rapid fixation and phosphorylation-state-specific immunohistochemistry to quantitatively characterize changes in activated ERK1/2 (pERK) immunopositive cell numbers. Beginning on postnatal d 8, E2 significantly influenced the number of pERK-positive cells in a cell-specific manner that was dependent on concentration and age but not sex. In cerebellar granule cells on postnatal d 10, E2 or BPA increased pERK-positive cell numbers at low doses (10-12 to 10-10 M) and at higher (10-7 to 10-6 M) concentrations. Intermediate concentrations of either estrogenic compound did not modify basal ERK signaling. Rapid E2-induced increases in pERK immunoreactivity were specific to the ERK1/2 pathway as demonstrated by coinjection of the mitogen-activated, ERK-activating kinase (MEK)1/2 inhibitor U0126. Coadministration of BPA (10 -12 to 10-10 M) with 10-10 M E2 dose-dependently inhibited rapid E2 induced ERK1/2 activation in developing cerebellar neurons. The ability of BPA to act as a highly potent E2 mimetic and to also disrupt the rapid actions of E2 at very low concentrations during cerebellar development highlights the potential low-dose impact of xenoestrogens on the developing brain.

Original languageEnglish
Pages (from-to)5388-5396
Number of pages9
JournalEndocrinology
Volume146
Issue number12
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Cerebellar Cortex
Extracellular Signal-Regulated MAP Kinases
Estrogens
Cell Count
Neurons
MAP Kinase Signaling System
Mitogens
Estrogen Receptors
Cerebellum
Estradiol
Cell Death
Phosphotransferases
Immunohistochemistry
Phosphorylation
Gene Expression
Injections
Brain
Growth
bisphenol A

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{cfbb1855caf944c79a03ae8ad36e9f9c,
title = "Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: Potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A",
abstract = "In addition to regulating estrogen receptor-dependent gene expression, 17β-estradiol (E2) can directly influence intracellular signaling. In primary cultured cerebellar neurons, E2 was previously shown to regulate growth and oncotic cell death via rapid stimulation of ERK1/2 signaling. Here we show that ERK1/2 signaling in the cerebellum of neonatal and mature rats was rapidly responsive to E2 and during development to the environmental estrogen bisphenolA(BPA). In vivo dose-response analysis for each estrogenic compound was performed by brief (6-min) intracerebellar injection, followed by rapid fixation and phosphorylation-state-specific immunohistochemistry to quantitatively characterize changes in activated ERK1/2 (pERK) immunopositive cell numbers. Beginning on postnatal d 8, E2 significantly influenced the number of pERK-positive cells in a cell-specific manner that was dependent on concentration and age but not sex. In cerebellar granule cells on postnatal d 10, E2 or BPA increased pERK-positive cell numbers at low doses (10-12 to 10-10 M) and at higher (10-7 to 10-6 M) concentrations. Intermediate concentrations of either estrogenic compound did not modify basal ERK signaling. Rapid E2-induced increases in pERK immunoreactivity were specific to the ERK1/2 pathway as demonstrated by coinjection of the mitogen-activated, ERK-activating kinase (MEK)1/2 inhibitor U0126. Coadministration of BPA (10 -12 to 10-10 M) with 10-10 M E2 dose-dependently inhibited rapid E2 induced ERK1/2 activation in developing cerebellar neurons. The ability of BPA to act as a highly potent E2 mimetic and to also disrupt the rapid actions of E2 at very low concentrations during cerebellar development highlights the potential low-dose impact of xenoestrogens on the developing brain.",
author = "A. Zsarnovszky and Le, {Hoa H.} and Wang, {Hong Sheng} and Belcher, {Scott M.}",
year = "2005",
month = "12",
doi = "10.1210/en.2005-0565",
language = "English",
volume = "146",
pages = "5388--5396",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex

T2 - Potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A

AU - Zsarnovszky, A.

AU - Le, Hoa H.

AU - Wang, Hong Sheng

AU - Belcher, Scott M.

PY - 2005/12

Y1 - 2005/12

N2 - In addition to regulating estrogen receptor-dependent gene expression, 17β-estradiol (E2) can directly influence intracellular signaling. In primary cultured cerebellar neurons, E2 was previously shown to regulate growth and oncotic cell death via rapid stimulation of ERK1/2 signaling. Here we show that ERK1/2 signaling in the cerebellum of neonatal and mature rats was rapidly responsive to E2 and during development to the environmental estrogen bisphenolA(BPA). In vivo dose-response analysis for each estrogenic compound was performed by brief (6-min) intracerebellar injection, followed by rapid fixation and phosphorylation-state-specific immunohistochemistry to quantitatively characterize changes in activated ERK1/2 (pERK) immunopositive cell numbers. Beginning on postnatal d 8, E2 significantly influenced the number of pERK-positive cells in a cell-specific manner that was dependent on concentration and age but not sex. In cerebellar granule cells on postnatal d 10, E2 or BPA increased pERK-positive cell numbers at low doses (10-12 to 10-10 M) and at higher (10-7 to 10-6 M) concentrations. Intermediate concentrations of either estrogenic compound did not modify basal ERK signaling. Rapid E2-induced increases in pERK immunoreactivity were specific to the ERK1/2 pathway as demonstrated by coinjection of the mitogen-activated, ERK-activating kinase (MEK)1/2 inhibitor U0126. Coadministration of BPA (10 -12 to 10-10 M) with 10-10 M E2 dose-dependently inhibited rapid E2 induced ERK1/2 activation in developing cerebellar neurons. The ability of BPA to act as a highly potent E2 mimetic and to also disrupt the rapid actions of E2 at very low concentrations during cerebellar development highlights the potential low-dose impact of xenoestrogens on the developing brain.

AB - In addition to regulating estrogen receptor-dependent gene expression, 17β-estradiol (E2) can directly influence intracellular signaling. In primary cultured cerebellar neurons, E2 was previously shown to regulate growth and oncotic cell death via rapid stimulation of ERK1/2 signaling. Here we show that ERK1/2 signaling in the cerebellum of neonatal and mature rats was rapidly responsive to E2 and during development to the environmental estrogen bisphenolA(BPA). In vivo dose-response analysis for each estrogenic compound was performed by brief (6-min) intracerebellar injection, followed by rapid fixation and phosphorylation-state-specific immunohistochemistry to quantitatively characterize changes in activated ERK1/2 (pERK) immunopositive cell numbers. Beginning on postnatal d 8, E2 significantly influenced the number of pERK-positive cells in a cell-specific manner that was dependent on concentration and age but not sex. In cerebellar granule cells on postnatal d 10, E2 or BPA increased pERK-positive cell numbers at low doses (10-12 to 10-10 M) and at higher (10-7 to 10-6 M) concentrations. Intermediate concentrations of either estrogenic compound did not modify basal ERK signaling. Rapid E2-induced increases in pERK immunoreactivity were specific to the ERK1/2 pathway as demonstrated by coinjection of the mitogen-activated, ERK-activating kinase (MEK)1/2 inhibitor U0126. Coadministration of BPA (10 -12 to 10-10 M) with 10-10 M E2 dose-dependently inhibited rapid E2 induced ERK1/2 activation in developing cerebellar neurons. The ability of BPA to act as a highly potent E2 mimetic and to also disrupt the rapid actions of E2 at very low concentrations during cerebellar development highlights the potential low-dose impact of xenoestrogens on the developing brain.

UR - http://www.scopus.com/inward/record.url?scp=27844570800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27844570800&partnerID=8YFLogxK

U2 - 10.1210/en.2005-0565

DO - 10.1210/en.2005-0565

M3 - Article

VL - 146

SP - 5388

EP - 5396

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 12

ER -